Artificial placenta and artificial womb technologies to support extremely premature neonates
are advancing toward clinical testing in humans. Currently, no recommendations exist …

Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

In this paper, we explore how the prospect of artificial placenta technology (nearing clinical
trials in human subjects) should encourage further consideration of the loss experienced by …

Background Breakthroughs in animal studies make the topic of human application of
ectogenesis for medical and non-medical purposes more relevant than ever before. While …

A large body of literature considers the ethico-legal and regulatory issues surrounding
assisted conception. Surrogacy, however, within this body of literature is an odd-fit. It …

In this paper, I explore how viability, meaning the ability of the fetus to survive post-delivery,
features in the law regulating abortion provision in England and Wales and the USA. I …

Bioethics scholarship considering the possibility of gestating an embryo to full term in an
artificial womb (ectogenesis) often overstates the capacities of current technologies and …

Despite improvements in survival over the past few decades, pulmonary immaturity and the
use of mechanical ventilation have stunted reduction in short-and long-term morbidities for …

In this chapter, we explore a key claim that arises in the speculative bioethical and legal
literature on artificial wombs: namely, that by removing gestation from the body, this …

Liquid-based perinatal life support (PLS) technology will probably be applied in a first-in-
human study within the next decade. Research and development of PLS technology should …